|Bid||2,272.00 x 1734200|
|Ask||2,275.00 x 3034300|
|Day's Range||2,255.00 - 2,275.00|
|52 Week Range||18.65 - 2,275.00|
|PE Ratio (TTM)||1,154.82|
|Dividend & Yield||0.12 (2.04%)|
|1y Target Est||N/A|
Categories: Europe Stock Alerts Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Bank Hapoalim BM. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)
The chief financial officer of Teva Pharmaceutical Industries (TEVA.TA), Eyal Desheh, is stepping down and will likely be appointed chairman of Isracard, Bank Hapoalim's (POLI.TA) credit card company, Israeli news websites reported on Tuesday. Desheh joined Teva as CFO in 2008 and briefly served as acting CEO from October 2013 to February 2014. Teva was left without a permanent chief executive in February after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps.
Israeli billionaire Shari Arison has hired Bank of America Merrill Lynch to help sell part of her controlling stake in Israel's largest bank, Hapoalim , financial newspaper Calcalist reported on Wednesday. Calcalist, one of Israel's leading financial news outlets, said Arison hopes the move will jumpstart efforts to find a strategic partner who will buy at least half her shares. Both Arison Investments and Bank of America Merrill Lynch declined to comment.